Background: Widespread and effective use of molecular diagnostic tests is indispensable for protecting public health and containing the severe respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. More than 1 year into the pandemic, as resources have reached a point of depiction, grouping samples in pools of certain sizes appears to be a reasonable method to reduce both the costs and the processing time without necessitating additional training, equipment, or materials. Aims: To assess whether the pooling strategy that was used in past outbreaks and is used in blood tests prior to transfusion for screening large populations can also be used in SARS CoV-2 tests. Study Design: Diagnostic accuracy study. Methods: This prospective study was conducted with 2815 samples, sent to the coronavirus disease 2019 (COVID-19) Laboratory of our hospital between February 12 and 21, 2021, to be tested for the presence of SARS-CoV-2. The samples were examined individually and in pools of live 100 mu l taken from each sequential sample, using 3 different SARS-CoV-2 reverse transcription-polymerase chain reaction (RT-PCR) kits. the Allplex (TM) 2019-nCoV Assay kit (Seegene, Republic of Korea), the GeneMAP (TM) 2019-nCoV detection V.3 kit (GenMark, TOrkiye), and the Bio-Speedy (TM) SARS-CoV-2 Double Genetm (TM) RT-qPCR kit (Bioeksen. Turkiye) on the BioRAD CFX96 (TM) Touch (Bio-Rad Laboratories Inc., Hercules, CA, USA) platform available in our laboratory. Results: Following the extraction of serial dilutions prepared from the SARS-CoV-2 RNA positive (cycle of threshold: 20) sample, the standard curves of RT-PCR were analyzed. By evaluating the efficiency (E) values, all 3 kits showed high sensitivity and similar results; while the highest level was detected with the Allplex (TM) 2019-nCoV Assay kit in the nucleocapsid (N) gene (F: 124%), the lowest was detected with the Double Gene (TM) RT-qPCR kit in the N and ORF lab genes (E: 90%). Of the samples included in the study, only 1 positive sample with low viral load was found to be negative when studied by pooling. The total number of kits to be used in pooled tests and then to individually retest the 5 samples in positive pools was calculated as 827 and the savings rate as 69.91% (1968/2815). Conclusion: The pooling strategy is an effective approach to extend the inspect of limited testing resources and reagents available in certain periods of the COVID-19 pandemic. Testing by pooling samples requires improvement of RNA extraction methods and careful monitoring of RT-PCR test sensitivity to avoid missing low-positive entities. Therefore, based on the prevalence of COVID-19 in their regions, laboratories should conduct their own validation of pooling studies for RNA extraction and amplification methods they use.
23 May 2024 in Diagnostic Microbiology and Infectious Disease
Tularemia, caused by Francisella tularensis, is a zoonotic infection that typically presents with lymphadenopathy, acute tonsillitis or ulcerative skin lesions. Isolated lymphadenopathy with caseating necrotizing granulomatous inflammation is uncommon and can resemble malignancy or tuberculosis. Here, we present two cases of tularemia presenting with lymph node enlargement, with histopathology revealing caseating granulomas.Case 1 involved a 27-year-old woman with left axillary lymphadenopathy and no systemic symptoms. Serology and PCR confirmed tularemia, while tuberculosis and brucellosis were excluded. Treatment with gentamicin and ciprofloxacin resulted in regression within one month.Case 2 involved a 34-year-old woman with right inguinal lymphadenopathy and systemic symptoms initially misdiagnosed as tuberculosis. Anti-tuberculosis therapy was ineffective. Tularemia was confirmed during a local outbreak, and antibiotic therapy led to improvement.These cases emphasize that tularemia can mimic tuberculosis or malignancy. Awareness in endemic areas and appropriate testing are crucial for timely diagnosis and treatment.
1 June 2026 in Flora the Journal of Infectious Diseases and Clinical Microbiology